Dynamic models of schistosomiasis morbidity

Area of Science:

• Parasitology and Tropical Medicine
• Mathematical Modeling in Health

Background:

• Assessing schistosomiasis control program impacts on community morbidity is hampered by a lack of dynamic theoretical frameworks.
• Understanding the complex interplay between schistosomiasis infection and disease progression is crucial for effective public health interventions.

Purpose of the Study:

• To develop and parameterize a theoretical model of schistosomal morbidity.
• To differentiate morbidity caused by current heavy infection versus early and late chronic disease stages.
• To inform the assessment of health impacts from schistosomiasis control initiatives.

Main Methods:

• Developed a novel mathematical model to represent schistosomal morbidity dynamics.
• Parameterized the model using data on disease resolution post-treatment.
• Utilized correlations between infection prevalence/intensity and age-morbidity profiles for parameter fitting.

Main Results:

• Early-stage morbidity, such as hepatomegaly (Schistosoma mansoni, S. japonicum), shows potential for rapid resolution after treatment.
• Late-stage chronic disease manifestations, like liver fibrosis, exhibit very slow or no resolution.
• Similar patterns of early versus late morbidity resolution were observed for urinary tract morbidity (S. haematobium).

Conclusions:

• The developed model provides a framework for understanding schistosomiasis-related morbidity progression.
• Treatment efficacy varies significantly between early and late stages of chronic schistosomiasis.
• Interventions targeting early disease stages may yield more rapid and complete health improvements.